1 llness onset included malaise, myalgias, and low-grade fever.

2  regimen were minor and limited and included low-grade fever and headache.

3                                    Prolonged low-grade fever and raised inflammatory markers led to t

4                        One patient developed low-grade fever, chills, cough, and malaise 3 days prior

5 verse events attributed to OKT3 consisted of low-grade fever (five patients), transient hypoxemia (th

6                     Diarrhea (six subjects), low-grade fever (five subjects), and vomiting (two subje

7                                              Low-grade fever (> or = 38.1 degrees C) after the first

8     The most common associated symptoms were low-grade fever, headache, neck stiffness, arthralgia, m

9        The most frequent toxicities included low-grade fever, hypoxia, and dyspnea.

10    The approach was well tolerated with only low-grade fever, myalgias, and fatigue reported and 2 pa

11 -containing derivatives of chi4073 developed low-grade fevers on day 10 or 12 after ingestion.

12 ine was generally well tolerated, although a low-grade fever or mild diarrhea occurred in six (22%) o

13 ter RF ablation, 15 (42%) patients developed low-grade fever (P < .001), 29 (81%) had flulike symptom